中西医整合乳腺癌长期用药专家共识
Expert consensus on long-term medication for breast cancer integrating Chinese and Western medicine
中国抗癌协会中西医整合乳腺癌专业委员会 朱世杰
摘要
随着乳腺癌患者总生存期(OS)的延长,乳腺癌长期用药问题引起了广泛的关注.然而,目前尚未有相关指南和共识针对乳腺癌患者中西医整合长期用药问题进行较为全面的指导和规范.中国抗癌协会中西医整合乳腺癌专业委员会专门针对乳腺癌中西医整合长期用药问题召开了 3次研讨会,并最终制定了本共识.旨在进一步提高乳腺癌患者长期用药依从性,使患者能够达到有效的药物使用时长,并提高患者生活质量、延长OS.
Abstract
With the prolongation of the survival period of breast cancer patients,the issue of long-term medication for breast cancer has attracted widespread attention.However,there are currently no relevant guidelines or consensus provi-ding comprehensive guidance and standards for the integration of Chinese and Western medicine in the long-term medica-tion of breast cancer patients.The Professional Committee for Holistic Integrative Chinese and Western Medicine in Breast Cancer Treatment of the China Anti-Cancer Association held three symposiums specifically addressing the issue of long-term concurrent use of Chinese and Western medicines in breast cancer patients,ultimately formulating this consen-sus.This consensus aims to further improve the long-term medication compliance of breast cancer patients,enabling pa-tients to achieve effective duration of drug use,and improve their quality of life and prolong survival.
关键词
乳腺肿瘤/长期用药/整合医学/中西医整合/专家共识Key words
breast cancer/long-term medication/holistic integrative medicine/the integration of Chinese and Western med-icine/expert consensus引用本文复制引用
出版年
2024
NETL
NSTL
万方数据